Nutritional and Metabolic Diseases

441 trials 157 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

A clinical study of MK-4082 in healthy people (MK-4082-001) Ended

2025-522100-25-00 Weight management 1 2025-10-09
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in the tre… Ended

2025-522975-27-00 Not applicable (submitted trial is a BE study in health 2 2025-09-29
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2025-522976-10-00 Not applicable (submitted trial is a BE study in health 2 2025-09-10
The bioavailability study of Dapagliflozin Ended

2025-522234-31-00 not applicable (submitted trial is a bioequivalence stu 2 2025-08-20
A single-center pilot study to establish a novel hypoglycemic clamp procedure to assess the time to spontaneous recovery from hypoglycemia i… Ended

2025-520996-16-00 Type 2 Diabetes Mellitus 9 2025-07-02
A study to test how insulin NNC0471-0119 works in the body in participants with type 2 diabetes when given by an insulin pump. Ended

2024-520230-29-00 Diabetes mellitus type 2 3 2025-07-01
Vonafexor in Impaired Renal Function and Suspected MASH Ended

2023-509192-16-00 Impaired renal function and suspected MASH 4 2025-07-01
Defining the Glucagon Unit: Investigating the Impact on Energy Expenditure and Glucose Level Deviation in healthy volunteers Ended

2024-510885-17-01 Obesity 3 2025-06-01
A Study to Understand What the Body Does to the Study Medicine Called PF-07976016 When Taken by Healthy Adults Ended

2024-518535-11-00 Obesity 3 2025-05-30
A PilOt dose-escalation trial with EMP16 in preparation for Phase III – the POEM trial Ended

2024-520122-11-00 Obesity 4 2025-05-07
A phase 1, open-label trial in healthy subjects and in subjects with diabetes investigating pharmacokinetics, tolerability, safety, and food… Ended

2024-515078-28-00 Diabetic Retinopathy 3 2025-04-16
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity Ended

2024-513679-42-00 Obesity 4 2025-04-09
A clinical research study investigating how the body processes the new compound petrelintide in people with kidney problems Ended

2024-518124-77-00 Weight management 3 2025-03-26
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharma… Ended

2023-506723-28-00 Mitochondrial encephalomyopathy, lactic acidosis and st 4 2025-03-20
The rimegePant in RElation to obeSiTy in mIGrainE study Ended

2024-513359-34-00 Obesity 6 2025-03-10
Phase 1 study assessing the pharmacokinetics of NEX-22A in subjects with T2D Ended

2023-508054-25-01 Type 2 diabetes 3 2025-02-26
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults with Type 2 Diabetes M… Ended

2024-512562-34-00 Type 2 Diabetes Mellitus 4 2025-02-24
A weight loss study evaluating subcutaneous treatment withAZD9550 and AZD6234 in combination, against placebo or each of the drugs alone Ended

2024-516176-15-00 Investigating obesity or overweight condition correlate 4 2025-02-24
A research study comparing different ways of increasing the dose of NNC0519-0130 in participants with overweight or obesity Ended

2023-508940-23-01 Type 2 diabetes mellitus 3 2025-02-21
A study to test how insulin NNC0471-0119 H works in the body in participants with type 1 diabetes when given by an insulin pump. Ended

2024-513472-18-00 Diabetes mellitus type 1 3 2025-01-23
A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide Ended

2024-516901-21-00 Weight management 3 2024-12-23
Once-weekly petrelintide versus placebo for obesity or overweight with comorbidities Ended

2024-512549-18-00 Weight management 4 2024-12-19
Study to investigate the safety and activity of Pegzilarginase in children under two years of age with Arginase 1 Deficiency Ended

2024-510797-25-00 Arginase 1 deficiency (ARG1-D) 5 2024-12-18
A Phase 1 Trial Assessing Pharmacokinetics and Safety of CAM2056 (Semaglutide Subcutaneous Depot) Ended

2024-518040-21-00 Body weight management 1 2024-12-18